Lobbying

Caris Science's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.

Caris Science

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$120K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Caris Science lobbying by quarter
Caris Science lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$40K1
Q2 2023$40K1
Q3 2023$40K1
Q4 2023$40K1
Q1 2024$40K1
Q2 2024$40K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$40K1
Q2 2026$40K1
Q3 2026$00

By issue

  • Medicare and Medicaid$256.7K · 15 reports
  • Health issues$216.7K · 14 reports
  • Medical research and clinical labs$116.7K · 9 reports
  • Copyright, patent and trademark$10K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Centers For Medicare and Medicaid Services (CMS)1 reports
  • Health & Human Services, Dept of (HHS)1 reports

Firms it paid

Firm
Splitoak Strategies$600K15 quarters

Former officials lobbying for it

Former position
AMY JENSENSpecial Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy AnalystQ2 2026
SARAH KUEHL EGGELegislative Assistant to Senator Bob Kerrey (1998-2000); Senior Budget analyst for Democratic Staff of the Senate Budget Committee (2001-2012); Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)Q4 2024

Lobbying reports

Filed by
07/20for Q2Splitoak Strategies$40K
05/04for Q1Splitoak Strategies$40K
01/20for Q4 2025Splitoak Strategies$40K
25/10/20for Q3 2025Splitoak Strategies$40K
25/07/21for Q2 2025Splitoak Strategies$40K
25/04/21for Q1 2025Splitoak Strategies$40K
25/01/21for Q4 2024Splitoak Strategies$40K
24/10/21for Q3 2024Splitoak Strategies$40K
24/07/22for Q2 2024Splitoak Strategies$40K
24/04/22for Q1 2024Splitoak Strategies$40K
24/01/22for Q4 2023Splitoak Strategies$40K
23/10/20for Q3 2023Splitoak Strategies$40K
23/07/20for Q2 2023Splitoak Strategies$40K
23/04/20for Q1 2023Splitoak Strategies$40K
23/01/20for Q4 2022Splitoak Strategies$40K